Gates foundation gives $5.7 mn for Ebola fight

Image
IANS New York
Last Updated : Nov 19 2014 | 12:50 PM IST

The Bill and Melinda Gates Foundation has committed $5.7 million for the fight against the deadly Ebola virus disease.

The foundation has decided to support efforts in Guinea and other Ebola-affected countries to scale up the production and evaluation of convalescent plasma and other convalescent blood products as potential therapies for people infected with the Ebola virus.

Various drug candidates will also be evaluated, including the experimental antiviral drug Brincidofovir, the foundation said Tuesday in a statement.

The programme will focus on treatments derived from the blood of survivors.

"The grant will also be used to evaluate new experimental drugs for Ebola," said a statement issued by the foundation.

More than 5,000 people have died in the current Ebola outbreak -- almost all of them in West Africa.

There is currently no licensed treatment or vaccine for the Ebola virus. Hospital treatment is based on giving patients intravenous fluids to stop dehydration and antibiotics to fight infections.

There are however several experimental vaccines and drug treatments for Ebola under development, but these have not yet been fully tested for safety or effectiveness.

International medical humanitarian organisation Medecins Sans Frontieres (MSF) had announced last week that it would host clinical trials in three Ebola treatment centres in West Africa in December.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 19 2014 | 12:46 PM IST

Next Story